Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine effect on EEG in closed-loop anesthesia
NCT05943028Phase 1Unknown
- Start
- Jul 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of esketamine in general anesthesia (2 arms). Primary endpoints: EEG NI value and Anesthesia maintains drug consumption. Status: unknown.
02
Drugs
esketamine
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05943028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943028.